Radiopharmaceuticals Market

Radiopharmaceuticals Market

Radiopharmaceuticals Market

Healthcare & Life Sciences


Reports and Insights


September 2022


Radiopharmaceuticals Market Overview

The report is titled as ‘Radiopharmaceuticals Market: Opportunity Analysis and Future Assessment 2022-2030’. An overview of conceptual frameworks, analytical approaches of the Radiopharmaceuticals market is the main objective of the report, which further consists the market opportunity and insights of the data involved in the making of the respective market.

Reports & Insights Overview

The non-identical approach of Reports and Insights stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give better opportunity for the customers to put their effort.

A research report on the Radiopharmaceuticals market by Reports and Insights is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that supports market and the factors that are acting as impedance for the growth of the market. Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market.

Radiopharmaceuticals Market Segmentation

The radiopharmaceuticals market is segmented on the basis of type, radioisotope, source, application, end user, and region.

By Type

Diagnostic Radiopharmaceutical

Therapeutic Radiopharmaceutical

By Radioisotope

Tec. 99


Iodine 131

Leutetium 177

Yttrium 90

Gallium 68

Gallium 67

Rubidium 82

Iodine 123

Iodine 125

Indium 111


By Source


Nuclear Reactors

By Application








By End User


Diagnostic Imaging Centers

Ambulatory Surgical Centers

Cancer Research Institute

By Region

North America

Latin America


Asia Pacific

Middle East


Radiopharmaceuticals Market Key Players

Some of the key participating players in radiopharmaceuticals market are:

Siemens Healthineer

Halyard Health


Life Molecular Imaging

Eli Lilly

Blue Earth Diagnostics

Progenics Pharmaceuticals, Inc.


GE Healthcare

Advanced Accelerator Applications

Telix Pharmaceuticals, Inc.

Cardinal Health

IsoTex Diagnostics

Lantheus Medical Imaging

NorthStar Medical Radioisotopes LLC

Bayer HealthCare Pharmaceuticals Inc.

Bracco Diagnostics

Eckert & Ziegler

Lantheus Medical Imaging, Inc.

Nordion, Inc.

Advanced accelerator applications S.A.

Factors that are benchmarked while estimating the market

Various factors that are benchmarked while estimating the market growth includes (but not restricted to):

New product developments and launches

Global Healthcare Industry Outlook

Radiopharmaceuticals Adoption Rate, by End User

Top Companies Historical Growth Rate

Pricing Impact

Advantages of Radiopharmaceuticals

Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to take informed decision.

A mix of top-down and bottom-up approach is followed to arrive and validate our market value estimations. For a product segment like wherein one/two manufacturer(s) dominates the market, it’s product sales, previous growth rates and market expansion plans are considered to generate market share in the market.

Frequently Asked Question

What is the projected market size & Compound Annual Growth Rate (CAGR) of the radiopharmaceuticals market?

The radiopharmaceuticals market is estimated to reach at a value of US$ *** Mn by the end of 2022 and expected to reach at a value of US$ *** Mn by 2030 with a significant CAGR of ***%.

Which base year is used in the radiopharmaceuticals market report?

The base year for the report is 2021 in radiopharmaceuticals market.

What segments are covered in radiopharmaceuticals market report?

The radiopharmaceuticals market is segmented on the basis of type, radioisotope, source, application, end user, and region.

What are the key participating players in the radiopharmaceuticals market?

Some of the key participating players in radiopharmaceuticals market are: Siemens Healthineer, Halyard Health, Curium, Life Molecular Imaging, Eli Lilly, Blue Earth Diagnostics, Progenics Pharmaceuticals, Inc., Zionexa, GE Healthcare, Advanced Accelerator Applications, Telix Pharmaceuticals, Inc., Cardinal Health, IsoTex Diagnostics, Lantheus Medical Imaging, NorthStar Medical Radioisotopes LLC, Bayer HealthCare Pharmaceuticals Inc., Bracco Diagnostics, Eckert & Ziegler, Lantheus Medical Imaging, Inc., Nordion, Inc., Advanced accelerator applications S.A.